Amarin Corp Plcuk (AMRN) Accounts Payables (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Accounts Payables of $48.2 million for Q1 2026, up 5.46% YoY from $45.7 million in Q1 2025, and up 6.17% sequentially from $45.4 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Accounts Payables (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Accounts Payables across 17 years of filings, most recently posting $48.2 million for Q1 2026.

  • In Q1 2026, Accounts Payables rose 5.46% year-over-year to $48.2 million; the TTM figure through Mar 2026 stood at $48.2 million (up 5.46% YoY), while the FY2025 annual figure was $45.4 million, up 12.36% from the prior year.
  • Accounts Payables climbed to $48.2 million in Q1 2026, from $45.4 million in the prior quarter.
  • Over the last five years, Accounts Payables for AMRN reached as high as $116.3 million in Q2 2022 and fell as low as $36.7 million in Q3 2025.
  • The 5-year median for Accounts Payables is $53.4 million (2023), against an average of $59.3 million.
  • Annual changes were most pronounced in 2022 — Accounts Payables climbed 28.64% — and 2023, when it plunged 53.31%.
  • A 5-year view of Accounts Payables shows it stood at $64.6 million in 2022, then fell by 18.33% to $52.8 million in 2023, then declined by 23.49% to $40.4 million in 2024, then grew by 12.36% to $45.4 million in 2025, then climbed by 6.17% to $48.2 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $48.2 million, $45.4 million, and $36.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.03 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 10.46 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 33.77 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -22.51 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.86 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 645.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 4.51 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 48.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 48.15 Mn
Dec 31, 2025 45.36 Mn
Sep 30, 2025 36.71 Mn
Jun 30, 2025 44.71 Mn
Mar 31, 2025 45.66 Mn
Dec 31, 2024 40.37 Mn
Sep 30, 2024 40.51 Mn
Jun 30, 2024 54.38 Mn
Mar 31, 2024 67.60 Mn
Dec 31, 2023 52.76 Mn
Sep 30, 2023 53.36 Mn
Jun 30, 2023 54.31 Mn
Mar 31, 2023 58.78 Mn
Dec 31, 2022 64.60 Mn
Sep 30, 2022 93.16 Mn
Jun 30, 2022 116.31 Mn
Mar 31, 2022 90.75 Mn
Dec 31, 2021 114.92 Mn
Sep 30, 2021 72.42 Mn
Jun 30, 2021 141.25 Mn